TransMedics to report Q3 2026 financial results on Nov 5 with a live conference call.

TransMedics Group, a leader in organ transplant technology, will announce its third quarter 2026 financial results after market close on November 5, 2026. The company will host a conference call for investors to discuss the results, accessible via phone and webcast. This update is important for investors tracking TransMedics' progress in advancing organ preservation and transplant therapies for heart, lung, and liver failure patients.

As of Oct 23, 2026 03:21 WIB, TransMedics Group Inc (TMDX) shares trade at USD 71.84 on Pluang, showing a 0.77% decline in the past day. The stock holds a market capitalization of $2.51 billion and an enterprise value of $2.91 billion. Investor interest remains strong with 100% buy orders on the platform, ahead of the company's Q3 financial results announcement on November 5, 2026.